L'Oréal (LRLCY)

The desk's stance

On our research list, not on the slate.

What the company does

The industry's $240B superpower — Maybelline, NYX, and L'Oréal Paris own the mass shelf e.l.f. is raiding, while Lancôme and CeraVe cover every other price point.

Why it matters: e.l.f. dethroned L'Oréal's Maybelline as America's #1 mass cosmetics brand by unit share — the clearest scalp of the dupe era.

In short: Personal care and cosmetics manufacturer. Category: Global Beauty & Cosmetics Leader. Sector: Consumer Defensive, Household & Personal Products.

G-Street Value and Score

G-Street Value: $78.95, computed Oct 18, 2026 (confidence: medium).

How we got there: 50% analyst leg $94.91 (street consensus, after 8% optimism discount) + 50% GainStreet factor value $62.99 (18× fwd EPS anchored to consumer-defensive multiples). 2 analyst targets have no linked source and are shown but not counted; this value will not open a position until they are sourced.

G-Street Score: 53 out of 100 (Weak).

  • Top-line growth & guidance: 10 of 32
  • Margin power: 13 of 15
  • Revenue visibility & quality: 5 of 11
  • Profitability & balance sheet: 15 of 24
  • Capital allocation & governance: 3 of 6
  • Valuation, sentiment & momentum: 7 of 12

How the G-Street Value and Score are calculated

Our current thesis

Updated Oct 17, 2026

The thesis

  • Elite 74.4% gross margins and pricing power outpace prestige peers including Estée Lauder.
  • Dermatological Beauty and prestige fragrances supply durable, high-margin global cash generation.
  • Omnichannel breadth spanning retail, salon, and travel retail cushions localized consumer weakness.

Risks

  • Maybelline and NYX face aggressive retail shelf-space erosion from nimble challengers like ELF.
  • Sequential revenue deceleration from €12.15B to €11.62B highlights discretionary beauty volume fatigue.
  • At 26.0x forward P/E, shares offer limited valuation cushion if European retail weakens.

What we're watching

  • Resistance test near 52-week high of $95.48 versus recent support at $84.00.
  • Upcoming 3Q2026 revenue print to confirm top-line stabilization against €11.22B consensus estimate.
  • U.S. mass retail shelf-share trends for Maybelline and NYX versus low-cost competitors.

Latest

LRLCY has rebounded to $90.90, climbing into the upper half of its 52-week range ($78.82 to $95.48) at 26.0x forward earnings following an 8.4% two-week rally. Revenue expanded 5.8% year-over-year anchored by industry-leading 74.4% gross margins, though quarterly sales slipped sequentially from €12.15B to €11.62B. Core mass brands Maybelline and NYX face persistent retail shelf-share skirmishes against agile challengers like e.l.f. Beauty.

Key numbers

As of Oct 16, 2026: market cap $242.1B · revenue growth +5.8% year over year · gross margin 74.4% · net margin 13.9% · forward P/E 26.0.

On the Gainz Lab maps

Beauty map

Who it does business with

  • e.l.f. Beauty competes with L'Oréal — The mass crown. e.l.f. dethroned Maybelline as America's #1 mass cosmetics brand by unit share — the defining upset of the dupe era.